StockNews.com Upgrades Pro-Dex (NASDAQ:PDEX) to Strong-Buy

Pro-Dex (NASDAQ:PDEX) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Monday.

Pro-Dex Trading Down 2.6 %

Shares of Pro-Dex stock traded down $0.47 during trading on Monday, hitting $17.78. The stock had a trading volume of 24,702 shares, compared to its average volume of 8,064. The stock has a 50 day simple moving average of $17.81 and a 200 day simple moving average of $18.09. The company has a market capitalization of $60.81 million, a PE ratio of 30.66 and a beta of 0.55. The company has a quick ratio of 2.08, a current ratio of 3.45 and a debt-to-equity ratio of 0.25. Pro-Dex has a 1 year low of $14.51 and a 1 year high of $22.99.

Pro-Dex (NASDAQ:PDEX) last released its earnings results on Thursday, February 8th. The medical instruments supplier reported $0.14 earnings per share for the quarter. The business had revenue of $12.59 million for the quarter. Pro-Dex had a net margin of 4.13% and a return on equity of 6.50%.

Institutional Trading of Pro-Dex

An institutional investor recently raised its position in Pro-Dex stock. Punch & Associates Investment Management Inc. increased its stake in shares of Pro-Dex, Inc. (NASDAQ:PDEX) by 8.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 69,610 shares of the medical instruments supplier’s stock after purchasing an additional 5,235 shares during the quarter. Punch & Associates Investment Management Inc. owned approximately 1.96% of Pro-Dex worth $1,093,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 15.28% of the company’s stock.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.